Literature DB >> 35974916

Differences in the Intestinal Flora of Patients with Inflammatory Bowel Disease in Southwest China.

Tingting Wang1, Renlin Yu2, Lingling Zhu1, Xuean Wang1, Bin Yang1.   

Abstract

To study changes in the intestinal flora associated with inflammatory bowel disease (IBD) in the Han population of southwest China, 48 participants were enrolled, 18 of whom had been diagnosed with IBD. Stool samples were collected from the participants. Sequencing of 16S rRNA gene was used to measure and identify the components of the intestinal flora. Diversity analysis and multivariate statistical analysis were conducted to study differences in intestinal flora between patients with IBD and healthy controls. The goods coverage, observed species, Shannon, and Simpson indices of alpha diversity were different (p < 0.05). Beta diversity analysis yielded significant differences between groups (R = 0.5668, p = 0.001 < 0.05). Compared with the composition of the intestinal flora in healthy controls, the relative abundances of Proteobacteria (18.56% vs. 3.56%, p = 0.001) and Fusobacterium (2.08% vs. 0.35%, p = 0.005) were higher in patients with IBD. Therefore, this study provides insight into the role of the microbiome in IBD. Supplementary Information: The online version contains supplementary material available at 10.1007/s12088-022-01014-z. © Association of Microbiologists of India 2022.

Entities:  

Keywords:  16S rRNA gene; Alpha diversity; Beta diversity; Inflammatory bowel disease; Intestinal flora; Southwest China

Year:  2022        PMID: 35974916      PMCID: PMC9375786          DOI: 10.1007/s12088-022-01014-z

Source DB:  PubMed          Journal:  Indian J Microbiol        ISSN: 0046-8991


  29 in total

1.  Commentary: Reconciling Hygiene and Cleanliness: A New Perspective from Human Microbiome.

Authors:  Boxuan Yu; Bowei Yu; Ligen Yu
Journal:  Indian J Microbiol       Date:  2020-03-12       Impact factor: 2.461

2.  Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation.

Authors:  Benoit Chassaing; Tom Van de Wiele; Jana De Bodt; Massimo Marzorati; Andrew T Gewirtz
Journal:  Gut       Date:  2017-03-21       Impact factor: 23.059

Review 3.  Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease.

Authors:  Alexa R Weingarden; Byron P Vaughn
Journal:  Gut Microbes       Date:  2017-02-10

4.  Quantitative Metaproteomics and Activity-Based Probe Enrichment Reveals Significant Alterations in Protein Expression from a Mouse Model of Inflammatory Bowel Disease.

Authors:  Michael D Mayers; Clara Moon; Gregory S Stupp; Andrew I Su; Dennis W Wolan
Journal:  J Proteome Res       Date:  2017-01-23       Impact factor: 4.466

Review 5.  Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease.

Authors:  Hengameh Chloé Mirsepasi-Lauridsen; Bruce Andrew Vallance; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

Review 6.  Recent Advancements in the Development of Modern Probiotics for Restoring Human Gut Microbiome Dysbiosis.

Authors:  Roshan Kumar; Utkarsh Sood; Vipin Gupta; Mona Singh; Joy Scaria; Rup Lal
Journal:  Indian J Microbiol       Date:  2019-05-25       Impact factor: 2.461

Review 7.  Dysbiosis in gastrointestinal disorders.

Authors:  Christopher Chang; Henry Lin
Journal:  Best Pract Res Clin Gastroenterol       Date:  2016-02-16       Impact factor: 3.043

8.  Intestinal autophagy links psychosocial stress with gut microbiota to promote inflammatory bowel disease.

Authors:  Shu-Ling Wang; Bo-Zong Shao; Sheng-Bing Zhao; Xin Chang; Pei Wang; Chao-Yu Miao; Zhao-Shen Li; Yu Bai
Journal:  Cell Death Dis       Date:  2019-09-30       Impact factor: 8.469

Review 9.  The Emerging Biotherapeutic Agent: Akkermansia.

Authors:  Vipin Chandra Kalia; Chunjie Gong; Ramasamy Shanmugam; Hui Lin; Liaoyuan Zhang; Jung-Kul Lee
Journal:  Indian J Microbiol       Date:  2021-12-16       Impact factor: 2.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.